Literature DB >> 8019759

Differential action of (+)-amphetamine on electrically evoked dopamine overflow in rat brain slices containing corpus striatum and nucleus accumbens.

W J Wieczorek1, Z L Kruk.   

Abstract

1. The effects of (+)-amphetamine on electrically evoked dopamine overflow were examined in the rat brain slice containing either anterior caudate putamen (aCPu) or nucleus accumbens (NAc), by fast cyclic voltammetry. 2. (+)-Amphetamine (1 microM) caused a time-dependent increase in the extracellular concentration of dopamine ([dopamine]ex) due to displacement of dopamine from terminal sites. After a 40 min superfusion, [dopamine]ex in the aCPu was 0.617 +/- 0.117 microM and in the NAc was 0.270 +/- 0.04 microM. Pretreatment with (-)-sulpiride (1 microM) did not affect this action of (+)-amphetamine. 3. (+)-Amphetamine (1 microM) exhibited a complex and time-dependent effect on electrically stimulated dopamine overflow, evoked by 1p, 4p/10 Hz and 20p/20 Hz. 4. In the aCPu, (+)-amphetamine (1 microM) resulted in attenuation of dopamine overflow due to 1p and 4p/10 Hz but potentiation of dopamine overflow to 20p/20 Hz. (-)-Sulpiride (1 microM) prior to (+)-amphetamine (1 microM) reversed the attenuation of dopamine overflow evoked by 1p and 4p/10 Hz but had no significant effect on dopamine overflow evoked by 20p/20 Hz. 5. (+)-Amphetamine (1 microM) potentiated dopamine overflow in the NAc to all three stimuli. (-)-Sulpiride (1 microM) prior to (+)-amphetamine (1 microM), resulted initially, in a further potentiation of overflow, followed by a time-dependent attenuation of dopamine overflow to all three stimuli. 6. t1/2, the rate of removal of [dopamine]ex following electrical stimulation was not significantly different in the aCPu and NAc for any of the stimulation conditions. After a 40 min superfusion with (+)-amphetamine (1 MicroM), t1/2 for ip, 4p/10 Hz and 20p/20 Hz was significantly increased in both the aCPuand NAc, the increase in t1/2 being significantly greater in the aCPu than in the NAc.7. In conclusion, this study indicates that the dopamine displacement and uptake inhibitory actions of(+ )-amphetamine result in complex and differential effects on electrically evoked dopamine overflow in the aCPu and NAc.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019759      PMCID: PMC1910092          DOI: 10.1111/j.1476-5381.1994.tb14813.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.

Authors:  M Raiteri; F Cerrito; A M Cervoni; G Levi
Journal:  J Pharmacol Exp Ther       Date:  1979-02       Impact factor: 4.030

2.  Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain.

Authors:  A J Azzaro; C O Rutledge
Journal:  Biochem Pharmacol       Date:  1973-11-15       Impact factor: 5.858

Review 3.  Functional and pharmacological significance of brain dopamine and norepinephrine storage pools.

Authors:  B A McMillen; D C German; P A Shore
Journal:  Biochem Pharmacol       Date:  1980-11-15       Impact factor: 5.858

4.  Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons.

Authors:  A S Horn; J T Coyle; S H Snyder
Journal:  Mol Pharmacol       Date:  1971-01       Impact factor: 4.436

5.  A superfusion chamber suitable for maintaining mammalian brain tissue slices for electrical recording [proceedings].

Authors:  C D Richards; W J Tegg
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

Review 6.  Neurotransmitter regulation of dopamine neurons in the ventral tegmental area.

Authors:  P W Kalivas
Journal:  Brain Res Brain Res Rev       Date:  1993 Jan-Apr

7.  Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.

Authors:  J F Fischer; A K Cho
Journal:  J Pharmacol Exp Ther       Date:  1979-02       Impact factor: 4.030

8.  In vivo monoamine oxidase inhibition by d-amphetamine.

Authors:  H H Miller; P A Shore; D E Clarke
Journal:  Biochem Pharmacol       Date:  1980-05-15       Impact factor: 5.858

9.  Inhibition of [3H]dopamine accumulation in rat striatal synaptosomes by psychotropic drugs.

Authors:  J Hyttel
Journal:  Biochem Pharmacol       Date:  1978-04-01       Impact factor: 5.858

Review 10.  The actions of amphetamine on neurotransmitters: a brief review.

Authors:  K E Moore
Journal:  Biol Psychiatry       Date:  1977-06       Impact factor: 13.382

View more
  11 in total

1.  Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.

Authors:  S J Cragg; S A Greenfield
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Amphetamine Dose-Dependently Decreases and Increases Binge Intake of Fat and Sucrose Independent of Sex.

Authors:  Katherine Stuhrman West; Valen Lawson; Andrew M Swanson; Anna I Dunigan; Aaron G Roseberry
Journal:  Obesity (Silver Spring)       Date:  2019-09-27       Impact factor: 5.002

3.  Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.

Authors:  Y Schmitz; C J Lee; C Schmauss; F Gonon; D Sulzer
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

Review 4.  How addictive drugs disrupt presynaptic dopamine neurotransmission.

Authors:  David Sulzer
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

5.  Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.

Authors:  Carrie E John; Sara R Jones
Journal:  Neuropharmacology       Date:  2007-03-16       Impact factor: 5.250

6.  Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats.

Authors:  James P Kesby; Xiaoying Cui; Jonathan O'Loan; John J McGrath; Thomas H J Burne; Darryl W Eyles
Journal:  Psychopharmacology (Berl)       Date:  2009-11-18       Impact factor: 4.530

7.  Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation.

Authors:  J Harvey; M G Lacey
Journal:  J Physiol       Date:  1996-04-01       Impact factor: 5.182

Review 8.  Presynaptic dopamine modulation by stimulant self-administration.

Authors:  Rodrigo A Espana; Sara R Jones
Journal:  Front Biosci (Schol Ed)       Date:  2013-01-01

9.  Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia.

Authors:  James P Kesby; Xiaoying Cui; Thomas H J Burne; Darryl W Eyles
Journal:  Front Cell Neurosci       Date:  2013-07-17       Impact factor: 5.505

10.  Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function.

Authors:  Charbel S Fawaz; Philippe Martel; Damiana Leo; Louis-Eric Trudeau
Journal:  BMC Neurosci       Date:  2009-08-14       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.